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Abstract : 
The development of endocavitary dual-mode probes is essential for the accurate 
treatment of many deep seated cancers which require a high imaging resolution and the 
capacity to selectively treat focal areas in the region of interest. The MULTIP project is aimed 
at using state-of-art piezoelectric technologies to design dual-mode ultrasonic probes for 
cancer-foci treatment and monitoring. In order to allow an efficient surgery planning, the 
technical study has been accompanied by a volume processing study permitting the design of 
the ultrasonic imaging/therapy process based on high-resolution−high-quality MRI images. 
Several prototypes were designed based on a simulation study and implemented: 1) two 
successive wide-band dual-mode transducer allowing imaging at high resolution (6 MHz) on 
a wide field of view, and therapy at 3 MHz with a good transduction efficiency (48% and 
70%); 2) a therapy-only transducer matrix adapted to the desired curvature with a high 
transduction efficiency (70%). Finally, a registration study of MRI volumes on ultrasound 
volumes has shown that, because of the texture of the ultrasound images, it is more efficient 
to search at registering the surfaces of the volumes once they have been segmented in each 
modality, rather than trying to register the two data volumes directly.  
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1 Introduction 
Therapeutic ultrasound enables the irreversible destruction of deep biological tissue by a 
focused ultrasonic beam through the natural barriers such as the skin or mucous membranes 
without damaging them [1-4]. This technique allows minimally invasive therapies beneficial 
for both patients and health systems. Applications relating to the treatment of prostate cancer, 
uterine fibroids and atrial fibrillation have already received CE marking and / or approval by 
the FDA and are used in clinical routine [5-9]. Clinical applications accessible to therapeutic 
ultrasound can be split into groups characterized either in terms of connection to the patient’s 
body (extracorporeal or intracavitary), or in terms of imaging guidance (ultrasound, MRI or 
X-ray) or by the users of these technologies (surgeons in the operating room, interventional 
radiologists and radiotherapists). 
Extracorporeal devices implement large ultrasonic transducers to which it is relatively 
easy to add ultrasound imaging probes without disturbing the therapy ultrasonic fields. 
However, these devices are limited by the accessibility and the mobility of deeper organs. For 
example, only about 30% of the liver’s volume can be accessed extracorporeally, 70% 
remaining partially obscured by the rib cage. Moreover the liver and the kidney are organs 
which move under the effect of breathing.  
Endocavitary devices offer then interesting alternatives. They cover most applications: 
urological, gynecological, colorectal or gastroenterological, for which natural channels are 
well suited. Surgeons and interventional radiologists are also seeking such devices, easier to 
handle in the operating room or in an MRI enclosure. Endocavitary devices can be brought 
closer to the targeted organs, which allow to reduce the acoustic powers used and to employ 
higher frequencies for a better resolution, which in turns permits a better control of the 
movements of the organs and thus improves the accuracy of the treatment. The aim of the 
MULTIP project is to improve these devices (MULTIP being the acronym of “Matrice de 
transducteurs Ultrasonores pour La Thérapie et l’Imagerie de la Prostate”) by allowing them 
to meet the requirements of clinical applications: 
− Being small in size to be inserted into the narrower natural routes 
− Embed guiding means such as an ultrasound imaging transducer, 
− Enable precise treatment of small tumors detected at an early stage, 
− Being used in the operating room by a surgeon. 
The use of a minimally invasive therapy is usually related to the definition of a precise 
preoperative planning and an image driven guidance during the intervention. In this study, we 
focus on endorectal probes for the focal treatment of prostate cancer tumors. In this context, 
only a precise imaging solution will allow exploiting the treatment precision of our device. 
For the preoperative planning, only MRI can be used to visualize the prostate and even more 
discriminate the tumor with sufficient contrast and resolution. In a second step, the fusion or 
registration of this preoperative information on the per-operative ultrasound images is a prior 
to access to the necessary therapy precision.  
In this paper, we present a synthesis of the results of the studies conducted aiming at 
developing endocavitary probes designed for prostate cancer (PCa) treatment, which 
overcome the difficulties raised earlier: the treatment of a volume by 3D deflection of the 
ultrasound beam, allowing combination of therapy and imaging in the same probe, and as 
such further miniaturization of the devices; Image segmentation of the prostate to facilitate 
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treatment planning by allowing the fusion of the ultrasound images on acquired MRI 
volumes. Firstly, the methods for designing and testing the prototype transducers are 
presented before describing a new method for segmenting images of the prostate 
2 The MULTIP project: application of endocavitary devices to PCa 
treatment. 
In France in year 2006, the increase in prostate cancer occurrence has been estimated to 
be 100% compared to year 2000, raising the total number of men involved to 76 518 [10]. 
Current radical whole-gland surgery or radiotherapy often induce side-effects such as urinary 
incontinence, erectile dysfunction, and bowel toxicity [11]. Focal treatment of the cancer 
nodes instead of whole gland surgery is the best chance of maintaining satisfactory life style 
and reducing the impact of prostate cancer surgery on the society. High Intensity Focused 
Ultrasound (HIFU) technology is particularly well suited for focal treatment of prostate 
cancer since the procedure is non-invasive, effective thus offering an excellent benefice to 
risk ratio [8,9,12]. As of today two companies (EDAP-TMS and US HIFU) obtained market 
approval for localized prostate cancer treatment with HIFU. They both use ultrasound 
imaging technology to guide the treatment. Two companies (INSIGHTEC and PROFOUND 
MEDICAL) are starting clinical trials for the same application with MRI guidance. Table 1 
summarizes the achievements of the companies involved in the development of focused 
ultrasound therapy devices.  
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1
92 
1
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2
6 
US-HIFU 
(USA) 
SB 500 
X _   _ 10 00 
2
5 
1
0 
1
0 2 
GE / 
INSIGHTEC 
(Israel) 
Cancer Prostate 
_ X _ _ _ <
 50 2 1 3 1 
PROFO
UND MEDICAL 
Prototype 
_ X _ _ _ <
 20 _ 1 _ _ 
Table 1 : Summary of the companies involved in the development of focused ultrasound 
devices for PCa treatment 
An "Integrated Imaging" version of the Ablatherm® was put on the market in 2005. The 
geometry of the transducer has been modified to receive at its center an imaging cell. This 
geometric modification of the transducer had an impact on the geometry of the ultrasound 
beam and therefore the clinical performance. It was then necessary to extend the pre-clinical 
studies and clinical trials to find new processing parameters which allowed maintaining or 
improving the clinical performance of the new product. If the resulting performances are now 
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well established and recognized by many national authorities, there are still some limitations 
in particular in the use of transducers with a fixed focal length. It is limited to 45 mm, and the 
complete treatment of large prostates cannot be achieved in a single session . In 10% to 20% 
of cases it is necessary to use a second procedure. The fixed focus aspect also leads to over-
treat the central area of the prostate compared to the peripheral regions. 
The current trend is to perform focal therapy by only treating the diseased area within 
an organ [8,9,11,12]. Large treatment volume and time consuming procedure will not be 
required anymore. Multi elements transducer allowing electronic deflection of the ultrasound 
beam [13] combined with dual-mode imaging array will ensure complete and fast treatment 
procedure without necessity of complex device technologies integration making these devices 
compatible with both ultrasound and / or MRI guidance. 
3 Simulations and prototyping 
The general concept of dual-mode probe is presented on Figure 1. The purpose of the 
central dual-mode part of the probe is to allow both imaging and therapy from the same 
transducer surface. Therefore, no therapeutic ultrasound emission surface is lost due to the 
inclusion of an imaging-only transducer, which can be critical due to miniaturization 
constraints. A high frequency operation of the dual-mode array is required for achieving a 
good resolution, comparable to the current imaging systems (e.g. 6 MHz with the 
Ablatherm®). On the other hand, the dual-mode array should be operated at lower frequencies 
for therapy, as performed in the current systems (e.g. 3 MHz with the Ablatherm). Indeed 
treating at high frequencies would decrease the penetration and increase the risk of heating the 
intervening healthy tissues away from the focus.  
 
Figure 1: Design of the probe, with a dual-mode center part (gray) surrounded with 
elements dedicated to therapy-only. 
As such, the probe aimed at being developed is a dual-mode dual-frequency transducer. 
The imaging part should be capable of forming high resolution images on a field of view as 
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wide as possible allowing the visualization of the entire prostate, which implies an ability to 
steer the beam. In the context of this project, typical power transmit efficiency of a therapy 
transducer is about 60-70%, depending of electrical environmental conditions and electrical 
impedance matching circuits included in the electrical environment [14,15]. Given the dual-
mode nature of a section of the probe to be developed, the project aimed at developing a 
transducer with an efficiency as close as possible to these numbers. 
Simulations have been conducted using the Field II software [16] in order to determine 
the optimum probe parameters for both imaging and therapy modes: size of the elements, kerf 
width [17], and geometry. 
3.1 Numerical design of the imaging and therapy parts 
3.1.1 Imaging 
Simulation tools and models of transducers were implemented to assess the images 
obtained with different network configurations comparing them with those obtained with the 
current curved array Ablatherm® system. Simulations were conducted for two geometries: 
spherical and cylindrical. The scatterers map [18] used to simulate prostate exams in 
conjunction with the FieldII software [16] is provided on Figure 2. To synthesize the results 
obtained in MULTIP, it was found that the lateral resolution of cross-sectional images is 
always better with concave or cylindrical arrays, since they benefits from a much wider 
aperture (see Table 2). This is the case even if the frequency is decreased (for example 3 MHz 
while the frequency currently used is of the order of 7 MHz). The axial resolution obtained 
with the Ablatherm® configuration is comparable to the images formed with the dual-mode 
array configurations at 6 MHz, but twice as good than images formed at 3 MHz. In almost all 
configurations tested, in the absence of side lobes noise, we came to identify important 
structures on the images of phantom prostate. The appearance of speckle is isotropic, and 
interfaces are often more visible with the tested configurations than with the reference one. As 
the axial resolution is coarser (especially at 3 MHz), the rectal wall (parallel to the transducer) 
may be more difficult to discern. In general, we can conclude that in terms of resolution, the 
images formed at 6 MHz with dual-mode large strips are better than those obtained with the 
current configuration. For the images formed at 3 MHz, as the lateral resolution is better but 
the axial resolution much worse. A potential issue lies in the presence of grating lobes 
generated by the beam steering. In fact, prostate gland is greater than the imaging probe strip, 
and for obtaining an image covering the whole of the gland, the beam must be steered to 
enlarge the field of view. If the pitch is too large, grating lobes appear, and the noise they 
bring is in most cases unacceptable (Figure 3): in the prostate-phantom images, the noise 
greatly reduces the contrast, blurs the contours of the body and prevents discerning the 
structures. In conclusion, the pitch must be chosen to avoid the appearance of grating lobes. 
However, a too small pitch may set technological problems: in particular, a too large number 
of elements can become difficult to electrically wire and control. Conversely, the imaging 
frequency can be decreased; for example from 6 MHz to 3 MHz, and the pitch increased from 
150 µm to 300 µm. However, as discussed above, the resolution decreases with frequency. 
Another way to increase the pitch without raising the noise caused by the grating lobes is to 
limit the beam deflection angle. For this purpose, a moving sub-aperture technique can be 
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used. In this case a cylindrical geometry (focused in the elevation direction) is preferred to a 
spherical geometry, for which it would be necessary to compensate electronically the 
longitudinal curvature. The simulations showed that using this technique, the pitch can be 
increased (at least until 0.78λ) without occurrence of noise (Table 2), especially if it is 
acceptable to limit the lateral resolution of the image on the edges. The cylindrical 
configuration results shown on Figure 4 take advantage of all the aspects of the dual-
frequency dual-mode array. In this case we agree to degrade the resolution on the sides by 
reducing the transmit sub-aperture and the imaging frequency, but the resolution in the center 
of the image (where it is the most important) is optimal and no noise from the lobes network 
is observed. With this type of operation a pitch at 1.2λ for imaging at 6 MHz is acceptable. 
The geometry in elevation of the transducer array was also studied. The focal length in this 
direction was set to 60 mm (the focal length of the Ablatherm® therapy transducer). It has 
been shown that an elevation aperture of 5 to 8 mm gives a beam size in the elevation 
dimension comparable to that obtained with the current imaging array. 3D images of a 
phantom prostate obtained by translation of a transducer in transverse configuration showed 
that with an elevation aperture of 8 mm and a frequency of 6 MHz image quality comparable 
to that obtained with Ablatherm®.  
 
 
Figure 2: Left, an echogeneicity map derived from a segmentation of a B-mode image 
acquired on a prostate with the current ultrasound probe of the Ablatherm®. One 
distinguishes in particular the contours of the prostate, the rectal wall, urethra. The 
interfaces are drawn in white with a one-pixel line thickness. Right: Prostate phantom 
consisting of point scatterers (only a portion is shown for clarity of the image). 
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Figure 3: Simulated images (left: resolution array, right: B-mode image) for a concave 
probe (F = 60mm), 38mm in length, comprising 128 elements and operating at 6MHz 
Configuration 128 
elements 
192 
elements 
256 
elements 
128 
elements, 
3MHz 
Cylindrical 
192 elements 
Cylindrical 96 
elements 3MHz 
Cylindrical 
128 elements 
3-6 MHz 
Centre frequency (MHz) 6 6 6 3 6 3 3-6 
Nb elements 128 192 256 128 1292 96 128 
Pitch (µm, λ) 302; 1.18 201 ; 0.78 150; 0.59 302; 0.59 200; 0.78 400; 0.78 302; 0.59-1.18 
Nb of active elements 100 100 100 100 Variable       (F-
num = 2) 
Variable          
(F-num = 2) 
Variable       (F-
num = 2) 
-6 dB lateral resolution 
(current 850-1800 µm) 350-700 400-750 500-1000 750-1350 
800-900 
(center) 
1650-2000 
(center) 
800-1000 
(center) 
-6 dB axial resolution 
(current 200 µm) 300 300 300 550 300 600 300 (center) 
Noise level (current -54 
dB) -25 -32 -50 -50 -46 -42 -44 
Image width with noise < 
-40 dB, in mm; current 60 
mm) 
20 40 60 60 60 60 60 
Table 2 : Configurations tested (focal radius 60 mm, probe length 38 mm) and results in 
terms of resolution and noise level ( Nb: number; F-num: F-number). 
 
Figure 4: Simulated images (left: resolution array, right: B-mode image) for a transverse, 
cylindrical probe with 38 mm length, 128 elements and operating at 3 MHz (for the 
lines with the larger deflection) to 6 MHz (for the lines oriented along the z axis). 
The focal number is 2, except at the edges of the image where it is higher 
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3.1.2 Therapy 
In this section, the therapy-only part of the MULTIP probe is addressed. A dual-mode 
imaging array placed at the center of the therapy probe is assumed, and the rest of the 
available surface is used only for power transmission (Figure 1). The design parameters of the 
therapy part were empirically determined by taking into consideration both technological and 
functional constraints (Table 3). A full 2D grid for a 3D beam steering would lead to a 
prohibitively large number of elements. By limiting the maximum deflection angles and 
tolerating grating lobes to some extent, the array pitch can be increased and the total number 
of elements limited. The independent elements count can be further reduced by connecting 
electrically symmetrical elements in a 1.5D or 1.25D arrays configuration [15,17]. This 
approach was investigated in order to achieve a technologically feasible design. The curvature 
of the therapy surface, the type and method of focusing, and the elements grid have to be 
determined. Simulations were performed assuming that the propagation is linear, in a 
homogeneous medium, and the transducer is excited in harmonic regime, and no cavitation 
occurs. The transducer considered here is cylindrical. The ultrasonic fields obtained with the 
tested configurations were calculated using Field II. To estimate the tissue heating induced by 
the ultrasound exposures, a thermal model was developed.  
 
Actives dimensions Maximum of 57.5 mm (y axis) x 35 mm (x axis) 
Curvature Cylindrical (55 mm) 
Imaging array Inclusion of a 35 mm x 8 mm dual-mode array of 117 elements. 
Frequency 3 MHz, continuous. 
Number of elements Maximum of 400 elements (without the imaging array) for a maximum of 200 
electrical channels. 
Therapy method To be determined. 
Elements geometry (grid) Elements of identical surface, with a shape to determine. 
Treatment area A xz rectangle :-10mm < x < 10mm ; 20 mm < z <60 mm 
Table 3 : Configurations tested (focal radius 60 mm, probe length 38 mm) and results in 
terms of resolution and noise level (Nb: number; F-num: F-number). 
From the simulated ultrasonic field, knowing the attenuation in the tissues [14,19], the 
deposited heat power per unit volume is computed and used as a heat source term in the 
modified heat equation (bioheat transfer equation, or BHTE) [20]. This equation is solved 
numerically with the method proposed by [21]. The acoustic and thermal parameters used in 
the simulations are summarized in Table 4. 
 
Speed of sound 1540 m/s 
Attenuation 0.5 dB/cm/MHz 
Density 1050 kg/m3 
Heat capacity of the tissues 3639 J/kg/°C 
Heat conductivity of the tissues 0.56 W/m/°C 
Perfusion 30 kg/ m3/s 
Heat capacity of the blood 3825 J/kg/°C 
Blood temperature 37°C 
Table 4 : Acoustic and thermal parameters used for the simulations 
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3.1.2.1 Treatment strategy simulations 
Before studying the subdivision of the transducer’s surface, a treatment strategy must be 
chosen. In fact, the pattern of the elements in the array must be determined according to the 
focusing needs. Several types of treatments were considered: the scanning of the area to be 
treated with one or two focal points.  
A complete therapy sequence consists in juxtaposing several elementary lesions to treat 
completely the targeted zone. Typically, the probe is positioned so that the targeted zone is 
centered on its acoustic axis. Therefore, a treatment scheme where the targeted zone is 
scanned with pairs of elementary lesions that are symmetrical along the yz plane (as defined 
on Figure 1) can be used. In a classical approach, the two symmetrical lesions can be 
produced by switching a single ultrasound focal point between them. Considering the 
relatively long thermal time constants in the soft tissues, an almost equivalent temperature rise 
map can be obtained with a multi-focal beam focused on both the elementary lesions sites at 
the same time, by using the proper array excitation scheme. In this case, as the two lesions are 
symmetrical, the excitation pattern will also be symmetrical. This allows connecting 
electrically the elements that are symmetrical along the yz plane together, which divides the 
number of independent channels by two. Similarly, if the focal points are all in the xz plane 
(as specified in Table 3), a second symmetry plane (xz) allows dividing again by two the 
number of independent elements.  
Simulations were performed in order to compare the ultrasound fields and the 
temperature maps obtained with the classical approach (alternating single focal points), and 
the proposed approach (multiple symmetrical focusing). Results are displayed on Figure 5, 
which shows on the right the temperature elevation when the focal point is exposed until a 
target temperature of 72°C is reached, and then refocusing the transducer to a symmetrical 
focal point (the mirror image of the first relative to yz) until reaching 72°C. Figure 6 shows 
the ultrasound field obtained by focusing simultaneously on two symmetrical focal points in 
the plane yz. The simulated temperature rise for two simultaneous focal points is almost 
identical to the case of one focal point alternated rapidly.  
 
 
Figure 5: Field obtained with a single focal point located at one end of the targeted area 
for treatment. On the left, the transducer is represented with the local maxima of the 
acoustic field obtained by simulation. The color of the elements on the transducer 
indicates the phase of the excitation. A straight xz cut of the field is shown on the 
center (color scale in dB on the right figure). On the right is shown the spatial 
distribution of the temperature rise simulated for a shot towards the focal point, 
alternating with a shot to a symmetrical focal point (ISPTA = 1000 W/cm²). 
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Figure 6: Fields obtained by focusing on two focal points symmetrical along the plane yz. 
On the left, the transducer is represented with the local maxima of the acoustic field 
obtained by simulation. The color of the elements on the transducer indicates the 
phase of the excitation. The color of the local maxima (circles in the figure) indicates 
the intensity (color scale in dB on the right figure). A straight cut xz field is shown on 
the right.  
 
3.1.2.2 Study of the therapy transducer’s surface subdivision 
The choice was made to simulate the field and optimize the transducer’s surface 
subdivision for two symmetrical focal points, in order to reduce the number of independent 
elements. The goal is to optimize the acoustical intensity at the targeted area. The acoustic 
field and the corresponding temperatures have been computed for different types of 
subdivisions of the surface, illustrated on Figure 7. To perform the optimization (of the 
subdivision size or elements regrouping) the value of the calculated field for a set of control 
points in the targeted volume is compared to a reference value (desired acoustic intensity, 
obtained with an ideal reference).  Optimal grid parameters are searched by minimizing a cost 
function using a genetic algorithm [22]. The cost function is computed using the ratios 
between the actual intensity obtained at the checkpoints and the expected value (obtained with 
the ideal reference transducer). Acoustic fields’ profiles along the z axis, and the 
corresponding temperature rise, were calculated for the optimized configurations found and 
are compared on Figure 8. The configurations explored were a regular grid with a resolution 
to be optimized, an irregular grid with varying line and columns sizes, a regular grid of rows 
of different widths, and a regular grid of 1 mm side elements grouped to respect the 400 
maximum channels fixed by the specifications. Both configurations of irregular grid (groups 
of elements and irregular grid) give better quality profiles than those obtained for the regular 
grid configuration (for which the temperature rise on the rectal wall is little higher). 
11 
 
 
Figure 7: Examples of regular (a, 2 mm), irregular (b), grouped elements (c, 1 mm) and 
regular column of varying height (d). Elements electrically connected are displayed 
in the same color. 
 
Figure 8: Acoustic intensity profiles (1 and 3) and elevation of temperature after firing 
with an ISPTA of 1000 W/cm² interrupted after reaching a temperature of 72 ° C (2 and 
4), for the following configurations: regular grid, variable grid, groups of elements, 
regular column of varying height elements. Fields and temperatures are calculated for 
a focal length of 25mm (1 and 2) and 55mm (3 and 4). 
3.2 Prototyping 
Based on the study previously performed, prototypes have been designed by the project 
partner Imasonic (Voray sur l’Ognon, France). Two imaging arrays and one therapy array 
demonstrators have been fabricated. 
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3.2.1 Dual-mode prototype 
The imaging prototype was designed with the following characteristics derived from the 
simulation study: imaging at 6 MHz, therapy at 3 MHz, 96 elements, 300 µm pitch, 8 mm 
height, waterproof, the first prototype being plane and the second prototype having an 
elevation geometrical focus at 60 mm (Figure 9). 
 
 
Figure 9: Pictures of the second prototype of the dual-mode probe. 
3.2.1.1 Dual Mode imaging capabilities 
Imaging capacities were tested for the first prototype on an ATS tissue mimicking 
phantom (ATS Laboratories, Bridgeport, United States) and an Ultrasonix RP 500 ultrasound 
scanner (Ultrasonix, Richmond, Canada). The tests were performed by transmitting pulses at a 
5 MHz center frequency (maximum frequency allowed by the probe+scanner system). The 
image obtained is compared to the one obtained by connecting the Ablatherm® imaging 
probe to the scanner. Images are provided on Figure 10. The imaging tests results show that 
the image produced by the dual-mode probe is of greater quality than the one obtained on the 
previous Ablatherm® probe in similar imaging conditions. The Dual-mode probe developed 
allowed to perform the imaging at a high frequency, which demonstrates the capacity of such 
probe to ensure high resolution imaging, while being designed to work also at low frequency. 
For the second prototype (aiming at increasing the transduction efficiency, detailed further in 
the document), the spectra of the impulse responses for two of the elements of the probe (n°48 
and 49) are provided on Figure 11. The bandwidth of the resulting probe covers the 3 MHz - 6 
MHz range as expected. The impulse response is short, and is suitable for imaging purposes.  
13 
 
 
Figure 10: Images of the resolution array of the ATS phantom using the first prototype of 
Dual-mode probe (left) and the Ablatherm® probe (right).The resulting signal to noise 
ratio of the dual-mode probe proves superior to the one of the Ablatherm® probe in 
similar imaging conditions. 
 
Figure 11: Impulse response and its spectrum measured on element 48 (left) and 49 
(right) of the second imaging probe prototype 
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3.2.1.2 Dual-mode array therapy capabilities 
Regarding the therapy mode of the dual-mode transducer, the mean power transmit 
efficiency has been measured for both prototypes. The mean value obtained is 48% ± 2% for 
prototype 1, the maximum being reached at 4 MHz, which is typically insufficient, but the 
preliminary characterization results for prototype 2 gave a mean transduction efficiency of 
70% at the targeted 3 MHz centre frequency.  
3.2.2 Therapy prototype 
The therapy prototype was designed with the following characteristics derived from the 
simulation study: therapy at 3 MHz, 456 elements (according to a design similar to Figure 7-
a), 114 channels with symmetrical wiring, and geometrical focus at 60 mm. The prototype is 
shown on Figure 12-left.The transducer efficiency has been characterized as a function of the 
transmit frequency by the radiation force balance method. Results are provided on Figure 12-
right. The transmit efficiency reaches 70% at 3 MHz, which suitable for a therapy application. 
 
 
Figure 12: Pictures of the prototype of therapy probe (Left) and Therapy transducer 
power transmit efficiency for different frequencies (right). 
3.3 Segmentation and registration for intervention pre-planning 
A focal therapy for localized prostate cancer can be considered for a selected class 
patients [8,9]. One of the crucial issues is the precise localization of the tumor before the 
therapy planning and its precise position retrieval during the therapy. In a preoperative stage, 
among the various imaging modalities used for the exploration of the prostate tumors, only 
MRI can visualize the anatomy with sufficient contrast and resolution to discriminate the 
tumor within the prostate. However the delineation of the prostate on MRI, and even more the 
delineation of the tumor itself, is still an open problem (e.g. [23] for the prostate 
segmentation). In the per-operative stage, the imaging modality used to define and guide the 
HIFU therapy is 3D (or 2D in the case of a dual-mode probe) ultrasound imaging. In this 
imaging modality, the tumor itself cannot be discriminated within the prostate. Actually, only 
the transfer of the information extracted during the preoperative planning on the preoperative 
ultrasound image should allow retrieving the tumor location during the therapy.  This transfer 
requires a phase of registration or fusion between the 3D MRI volume and the ultrasound 
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images. Beside other considerations, several registration strategies can be considered 
according to the geometrical dimension (point, line, surface or volume) of the common 
information [21,24]. In the context of the MULTIP project two strategies are explored: 
volume to volume and surface to surface registration.  
3.3.1 Volume to volume registration 
By volume to volume we mean techniques that use the entire volume information to 
perform the registration. This class of techniques is also called intensity based registration. 
The main principle of these techniques is the following: 1) a similarity measure quantifies the 
degree of similarity between the intensity patterns in the two volumes, 2) geometrical 
transformations are performed on one volume in order to align it with the reference image, 3) 
the geometrical transformation which provide the highest similarity measure between the 2 
volumes is searched by an optimization process. This class of methods is known to be 
relatively robust but cannot be directly used on US images because their characteristic feature 
is speckle and the intensity distribution of the speckle is not directly related to the several 
tissues. As an exploratory work in the MULTIP project, we proposed to use a new similarity 
measure no more related to the intensities but more related to the spatial organization of the 
intensities (the texture of the intensities). Texture estimation tools had some success in 
ultrasound image analysis. But, in our case, the circular US probe provides an irregular spatial 
speckle organization in orientation and scale over the image. In our study we proposed to use 
a texture analysis tool based on orthogonal moment invariants with respect to scale and 
rotation. The first results showed that orthogonal moment invariants where able to 
characterize not only the several region on US images but also the boundary between two 
regions (see Figure 13). But orthogonal moment invariants failed on characterizing the 
prostate in T2 MRI because of high slice thickness and moreover of the non-homogeneous 
information provided by the several prostate zones. In conclusion, a similarity measure only 
based on orthogonal moment invariants could not be implemented. So either a mix of 
orthogonal moment invariants and gray level should be used or the fall-back solution (surface 
to surface registration) should be investigated. 
 
Figure 13: a) Original prostate image b) orthogonal moment invariant feature 
characterizing the regions c) orthogonal moment invariant feature characterizing the 
contours. 
3.3.2 Surface to surface registration 
Most of the work on MRI to ultrasound prostate image registration has been performed 
in this framework (e.g. the pioneer work of [25]). This framework is based on the delineation 
of the prostate external surface on both imaging modalities followed by an elastic registration 
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on both surfaces. The accuracy of the registration is highly related to the accuracy of the 
prostate surface extraction. In a first step, we explored the prostate surface extraction on the 
3D ultrasound volume provided by the Ablaterm® device. After a bibliographical research we 
decided to use a semi-automatic method in which the user defines 6 initial points (the prostate 
apex and base and 4 points in the mid axial prostate slice). These points allow defining an 
initial surface mesh. This surface is then refined on the US volume using the Discrete 
Dynamic Contour (DDC) or the Optimal Surface Detection (OSD) methods [26]. Both 
methods have some merits and have shown on the overall a quite good performance.  
They always fall within the intra- and inter-observer variability interval. However, the 
OSD-based approach (Figure 14-a) provides slightly better results in terms of accuracy and 
requires less computation resources. In a second step we adapted the OSD approach to the T2 
MRI prostate surface extraction. T2 MRI presents new segmentation difficulties in the sense 
that the prostate is not homogeneous (several prostate zones), its surface presents little 
information (hyposignal of the capsule) with gray level values close to these of the 
neighboring organs surface (bladder and rectum). We are working on a multi objects OSD 
segmentation scheme. Preliminary results on joint bladder and prostate segmentation can be 
seen on Figure 14-b. 
 
Figure 14: a) Prostate surface mesh extracted on a 3D US volume using Optimal Surface 
Detection. The color indicates the error between the estimated mesh and an expert 
contours extracted surface. b) Prostate (green) and bladder (red) surface meshes 
extracted on a T2 MRI volume using multi-objects Optimal Surface Detection. 
4 Discussion and conclusion  
The development of endocavitary dual-mode probes is essential for the accurate 
treatment of many deep seated cancers which require a high imaging resolution and the 
capacity to selectively treat focal areas in the region of interest. However the development of 
full 3D HIFU beam steering probes is extremely complex and the current technology does not 
allows cost effective manufacturing of such phased array therapy probes, and of the 
corresponding multi-channels electronics for delayed power transmissions. The MULTIP 
project aimed at determining under which conditions dual-mode ultrasonic probes can be 
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designed to fulfill the therapeutic requirements of cancer-foci treatment while corresponding 
to the current technology available, so as to design a system which can be viably implemented 
in a commercial device. In order to allow the system to take advantage of the cutting edge 
imaging modalities, and to allow an efficient surgery planning, the technical study has been 
accompanied by a volume processing study aiming at permitting the design of the ultrasonic 
imaging/therapy process based on high resolution-high quality MRI images. The study was 
initiated in simulations, in order to determine, given the constrains of the application, the key 
parameters which remained to be defined. Different combinations of parameters including 
number of elements, pitch, center frequency and shape, were explored. Results showed that it 
is necessary to have a dual-mode probe which allows performing the imaging at a high 
frequency for a high resolution, while permitting to perform the therapy at a lower frequency. 
Regarding imaging simulations, the minimization of the grating lobes showed that a pitch of 
1.2λ for imaging at 6 MHz is acceptable, but that the focal number needs to be adapted in 
different regions of the image to maintain an acceptable resolution. This implies the capacity 
of the probe to perform imaging also on a wide bandwidth. Regarding the therapy simulations 
the question of the number of simultaneous foci was studied, given that multiple foci allow 
the reduction of the number of electrical channels. However it has been observed that doing 
so reduces the energy transmitted to a given focus too severely in terms of local temperature 
elevation, and lead to the conclusion that a single focus was more efficient in terms of energy 
deposit. In order to further optimize the energy transmission, another study was conducted to 
determine the ideal therapy transducer subdivision. Such sub division impacts the beam shape 
and the energy deposit, but allows to reduce the number of power channels (limited here to 
400 maximum for manufacturing purposes) and to simplify the wiring of the resulting probe. 
Conclusion is that while the 400 hundred channels are required to optimize the beam shape 
and its deflection abilities, an irregular grid allows achieving superior targeting resolution. 
Based on these simulation results, prototypes have been manufactured and tested for 
imaging and therapy separately. Tests of the dual-mode section of the probe, showed that the 
bandwidth achieved is wide enough to cover the frequency domain established in simulation, 
and the transduction efficiency in therapy mode (48%, then 70%) show that the dual-mode 
section reaches the efficiencies required for power transmission. Imaging tests on an 
Ultrasonix RP500 scanner showed that the images performed are of better quality than the one 
obtained using the previous probe design in similar imaging conditions. These results confirm 
once more the choices made in the simulation study, and the capacity of the resulting probe to 
perform high resolution imaging while allowing to transmit power at a lower frequency.  
The study of the therapy probe prototype, which surrounds the dual-mode section, 
showed that the efficiency achieved is comparable to the one obtained in the previous but less 
complex models developed. The ratio of 70 % reached at 3 MHz demonstrates the high 
transduction capacity of the developed probe, which suggests that similar therapy efficiency 
should be achieved while allowing to take advantage of in-plane beam steering capacities. 
The following work planned before the end of this project include complementary 
characterizations of the second dual mode prototype (imaging & therapy capability) and of the 
therapy probe prototype (beam forming). 
Finally, registration study of MRI volumes on ultrasound volumes, for the accurate 
planning of therapy session, has shown that it is more efficient to search at registering the 
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surfaces of the volumes once they have been segmented ion each modality, rather than trying 
to register the two data volumes directly. Indeed the particular texture of the ultrasound 
images render direct registration difficult, and better success have been achieved by 
registering the surface of the prostates once each has been extracted from its own modality. 
While the current implementation is still semi automatic, which is still a common approach in 
intervention planning, future work will attempt to automate the segmentation and registration 
process. 
The combination of high resolution therapy planning with high resolution per-operatory 
imaging, real-time registration, and accurate beam-steered focal therapy will allow in the 
future a fast and precise surgery, able to treat the diseased areas while sparing the biological 
tissues which can be saved [27]. 
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